Hot Tech Stocks To Buy For 2018


The technological revolution of the past 15 years has posed well-documented and existential challenges for many of the print media behemoths of the twentieth century. Other publishers, however, have had their growth turbocharged by this transformation, bringing them inexorably to the attention of strategic and financial acquirers.

Specialist data providers capable of supplying their corporate clients with in-depth, real-time, sector-specific quantitative analytics and editorial insight are one category of media business riding a wave of inward investment. Their scalable, subscription-based business models mark these companies out as ideal targets for acquirers seeking the twin guarantees of recurring revenues and a transparent relationship between growth in these revenues and increased profitability.


A textbook example is provided by the acquisition of Incisive Insight, a division of the publishing group Incisive Media comprising specialist financial titles such as Risk.net and WatersTechnology, by French information services group Infopro Digital in March. And the deal is only one recent addition to the ongoing succession of mergers and acquisitions in the sector.

Hot Tech Stocks To Buy For 2018: Datawatch Corporation(DWCH)

Advisors’ Opinion:

  • [By Lisa Levin]

    Datawatch Corporation (NASDAQ: DWCH) shares were also up, gaining 14 percent to $8.10 after the company reported a narrower-than-expected quarterly loss.

Hot Tech Stocks To Buy For 2018: CYREN Ltd.(CYRN)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Cyren Ltd (NASDAQ: CYRN) got a boost, shooting up 41 percent to $2.33 after the company reported a strategic investment from Warburg Pincus Funds.

  • [By Lisa Levin] Companies Reporting Before The Bell Tyson Foods, Inc. (NYSE: TSN) is expected to report quarterly earnings at $1.38 per share on revenue of $9.86 billion. Aecom (NYSE: ACM) is projected to report quarterly earnings at $0.71 per share on revenue of $4.67 billion. JD.Com Inc(ADR) (NASDAQ: JD) is estimated to report quarterly earnings at $0.11 per share on revenue of $12.60 billion. 58.com Inc (ADR) (NYSE: WUBA) is projected to report quarterly earnings at $0.28 per share on revenue of $383.60 million. Kamada Ltd (NASDAQ: KMDA) is expected to report quarterly earnings at $0.02 per share on revenue of $25.00 million. Palatin Technologies, Inc. (NYSE: PTN) is projected to report quarterly earnings at $0.06 per share on revenue of $28.00 million. TheStreet, Inc. (NASDAQ: TST) is estimated to report a quarterly loss at $0.02 per share on revenue of $15.81 million. Atlantica Yield PLC (NASDAQ: ABY) is projected to report quarterly earnings at $0.45 per share on revenue of $290.80 million. Asure Software Inc (NASDAQ: ASUR) is estimated to report quarterly earnings at $0.15 per share on revenue of $15.26 million. Cyren Ltd (NASDAQ: CYRN) is expected to report quarterly loss at $0.06 per share on revenue of $7.90 million. Viewray Inc (NASDAQ: VRAY) is estimated to report quarterly loss at $0.12 per share on revenue of $18.58 million.

     

Hot Tech Stocks To Buy For 2018: Biogen Idec Inc(BIIB)

Advisors’ Opinion:

  • [By Todd Campbell]

    A new and highly anticipated study byCelgene Corp. (NASDAQ:CELG) shows that its promising multiple sclerosis drug could soon reshape the $19 billion multiple sclerosis market. On Friday, management reported that ozanimod met its primary endpoint for reducing MS relapses better than Biogen Inc.’s (NASDAQ:BIIB) Avonex, and importantly, it did so without any new safety risks.

  • [By Brian Orelli]

    While that’s fine for clinical trials, it may make it difficult for Ionis’ drugs to compete with drugs that work as well but don’t have side effects that need to be monitored. Of course, for Spinraza, which Biogen (NASDAQ:BIIB) and Ionis recently got approved for spinal muscular atrophy, side effects aren’t an issue because there aren’t any other treatment options at the moment.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Monday was Biogen Inc. (NASDAQ: BIIB) which traded down nearly 4% at $329.58. The stocks 52-week range is $244.28 to $348.84. Volume was 1.2 million matching the daily average of 1.2 million shares.

  • [By Ben Levisohn]

    Biogen (BIIB) tumbled to the bottom of the S&P 500 today after getting cut by two analysts.

    Agence France-Presse/Getty Images

    Biogen dropped 4.7% to $278.96 at 4:19 p.m. today, while the S&P 500 declined 0.2% to 2,381.38.

    Leerinks Geoffrey Porges cited the “slower than expected ramp for Spinraza” in cutting Biogen to Market Perform from Outperform, while Morgan Stanly’s Matthew Harrison wrote that his decision to cut Biogen to Market Weight from Overweight was “not a downside call, but a timing call.”


    Biogen’s market capitalization fell to $60.2 billion today from $63.2 billion yesterday. It reported net income of $3.7 billion on sales of $10.2 billion in 2016.

    Barron’s Teresa Rivas recommended buying Biogen in December after the company released positive trial data on its Alzheimer’s drug.

Hot Tech Stocks To Buy For 2018: Activision Blizzard, Inc(ATVI)

Advisors’ Opinion:

  • [By Danny Vena]

    With that much revenue at stake, what are the best gaming stocks for investors in 2017? Several companies have exhibited impressive performance over the past several years, and that trend is likely to continue. Top choices in the space includeActivision Blizzard, Inc. (NASDAQ:ATVI), Electronic Arts Inc. (NASDAQ:EA), and Take-Two Interactive (NASDAQ:TTWO).

  • [By John Ballard]

    Activision Blizzard (NASDAQ:ATVI) posted strong sales and earnings for the first quarter despite no new game releases, which spotlights the increasing importance of player engagement and growth. The company has been holding steady at 400 million monthly active users for its games since acquiring King Digital Entertainment in early 2016. Those users spent about 40 billion hours over the last 12 months playing the titles across its roster.

  • [By John Ballard]

    But now we are starting to see game publishers step up with that commitment. Two important new leagues to watch are Activision Blizzard’s (NASDAQ:ATVI) Overwatch League and Take-Two Interactive Software’s (NASDAQ:TTWO)NBA 2K eLeague. Activision Blizzard will soon start selling teams for Overwatch League to prospective owners this year, and the NBA and Take-Two just announced the formation of its own professional e-sports league based on the best-selling NBA 2K franchise.

  • [By Peter Graham]

    Note that in February 2016, King Digital Entertainment PLC (NYSE: KING) was acquired by Activision Blizzard, Inc (NASDAQ: ATVI) for $5.9 billion.

    A technical chart for Glu Mobile shows shares breaking and staying above a key resistance/supporting level at the $2.40 level:

Hot Tech Stocks To Buy For 2018: AXT Inc(AXTI)

Advisors’ Opinion:

  • [By Lisa Levin] Related CRMD Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher 12 Biggest Mid-Day Gainers For Tuesday CorMedix's (CRMD) CEO Khoso Baluch on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha) Related BIOA Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher Mid-Morning Market Update: Markets Edge Higher; Tiffany Earnings Top Estimates BioAmber (BIOA) Q4 2016 Results – Earnings Call Transcript (Seeking Alpha) CorMedix Inc. (NYSE: CRMD) shares fell 27.5 percent to $1.50 after the company reported Q4 results and issued a business update. Bioamber Inc (NYSE: BIOA) shares tumbled 23.6 percent to $2.40. BioAmber reported FY16 adjusted loss of $1.07 per share on revenue of $8.3 million. The Medicines Company (NASDAQ: MDCO) shares dipped 20.9 percent to $41.62. Innocoll Holdings PLC (NASDAQ: INNL) shares fell 20.3 percent to $1.49. Innocoll posted a narrower-than-expected quarter loss, but revenue missed estimates. Stifel Nicolaus downgraded Innocoll from Buy to Hold. Rosetta Genomics Ltd. (USA) (NASDAQ: ROSG) shares declined 20.3 percent to $3.83. On Thursday, Rosetta Genomics disclosed a 1-for-12 reverse stock split. Esperion Therapeutics Inc (NASDAQ: ESPR) shares dropped 19.9 percent to $23.76. Esperion Therapeutics shares have jumped 106.19 percent over the past 52 weeks, while the S&P 500 index has gained 16.70 percent in the same period. AmTrust Financial Services Inc (NASDAQ: AFSI) tumbled 18.3 percent to $17.65. AmTrust Financial disclosed that it will delay its annual report filing for the fiscal year ended December 31, 2016. Qualstar Corporation (NASDAQ: QBAK) slipped 17.7 percent to $6.85. Qualstar reported a Q4 loss of $0.20 per share on revenue of $2.2 milli

Hot Tech Stocks To Buy For 2018: Electronics for Imaging Inc.(EFII)


Advisors’ Opinion:

  • [By Lisa Levin]

    Electronics For Imaging, Inc. (NASDAQ: EFII) shares dropped 43 percent to $26.96. Electronics For Imaging disclosed that it has postponed Q2 release due to accounting issues related to revenue recognition. Morgan Stanley downgraded Electronics for Imaging from Equal-Weight to Underweight.